Jul 06, 2020-Monday

select city

Metro cities - Delhi, Mumbai, Chennai, Kolkata

Other cities - Noida, Gurgaon, Bengaluru, Hyderabad, Bhopal , Chandigarh , Dehradun, Indore, Jaipur, Lucknow, Patna, Ranchi

Monday, Jul 06, 2020
ADVERTISEMENT

Niaid

May 01, 2020 23:36
Remdesivir is an experimental antiviral drug developed by the US-based pharma major Gilead Sciences. It failed in trials against the Ebola virus and was found to have limited effects among patients in Wuhan, China, where the illness was first detected last year. read more
Apr 30, 2020 04:16
Gilead shares jumped as much as 7.1% Wednesday after the company’s statement. The news appeared to boost the entire U.S. stock market as well, with the S&P 500 gaining 2.4% despite data showing a deep contraction in the U.S. economy in the first quarter of the year. read more